AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FLUTICASONE PROPIONATE
55 registrations across 10 African markets— 42 active
Markets with FLUTICASONE PROPIONATE
🇿🇦South Africa
27 registrations
16 active
🇺🇬Uganda
10 registrations
10 active
🇹🇿Tanzania
5 registrations
5 active
🇿🇲Zambia
4 registrations
4 active
🇳🇬Nigeria
2 registrations
2 active
🇲🇼Malawi
2 registrations
0 active
🇲🇬Madagascar
2 registrations
2 active
🇿🇼Zimbabwe
1 registration
1 active
🇷🇼Rwanda
1 registration
1 active
🇰🇪Kenya
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Flusort Nasal Spray Nasal spray | 🇿🇲Zambia | Glenmark Pharmaceuticals Ltd | active | Apr 2031 |
| FLUSORT SPRAY, METERED; NASAL | 🇿🇼Zimbabwe | GLENMARK PHARMACEUTICAL LIMITED | active | Feb 2031 |
| Flutiair Nasal spray | 🇿🇲Zambia | Sava Healthcare Limited | active | Aug 2030 |
| Flomist Spray Spray For Nasal Use | 🇿🇲Zambia | Cipla Ltd | active | Jul 2030 |
| Flomist Spray Spray For Nasal Use | 🇿🇲Zambia | Cipla Ltd | active | Jul 2030 |
| TICANASE NASAL SPRAY Nasal Spray | 🇷🇼Rwanda | EUROPEAN EGYPTIAN PHARMACEUTICAL INDUSTRIES | active | Feb 2030 |
| Flixotide Evohaler 50 mcg** Aerosol, Metered-Dose | 🇳🇬Nigeria | GlaxoSmithKline Consumer Nigeria PLC (GSK) | active | Dec 2028 |
| Frinase nasal spray Nasal Spray, Suspension | 🇰🇪Kenya | Jerusalem Pharmaceuticals Co Ltd | active | Jul 2028 |
| Flusort Nasal Spray Spray, Metered-Dose | 🇳🇬Nigeria | Glenmark Pharmaceuticals Nigeria Limited | active | Feb 2026 |
| CIPLA-FLUTICASONE 250 DP-CAPS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA-FLUTICASONE 50 DP-CAPS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| FLOHALE 50 DP-CAPS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA-FLUTICASONE 100 DP-CAPS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| FLOHALE 250 DP-CAPS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| FLOHALE 100 DP-CAPS | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA-FLUTICASONE AQUEOUS NASAL SPRAY | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| SERETIDE 25/250 | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | suspended | May 2025 |
| SERETIDE 25/125 INHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | suspended | May 2024 |
| CUTIVATE CREAM | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | suspended | Nov 2023 |
| SERETIDE 25/50 INHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | suspended | Nov 2023 |
| FLIXONASE 500MCG NASAL SPRAY NASAL SPRAY | 🇲🇼Malawi | — | expired | Jun 2021 |
| FLOMIST 50MCG AQUEOUS NASAL SPRAY AQUEOUS NASAL SPRAY | 🇲🇼Malawi | — | expired | Jun 2012 |
| FLIXOTIDE 50 INHALER CFC-FREE | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| SERETIDE 50/250 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLIXOTIDE 50 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FOXAIR 50/500 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| SERETIDE 50/100 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLOMIST | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| FLIXONASE NASULES | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLIXOTIDE 100 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLIXOTIDE 125 INHALER CFC-FREE | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FOXAIR 50/250 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLIXONASE AQUEOUS NASAL SPRAY | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLIXOTIDE 250 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLIXOTIDE 250 INHALER CFC-FREE | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| SERETIDE 50/500 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLONASE AQUEOUS NASAL SPRAY | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| FOXAIR 50/100 ACCUHALER | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| FLUTICASONE
PROPIONATE NASAL SYSTEMIC
UNIT DOSE
AEROSOLS | 🇺🇬Uganda | DROGSAN İLAÇLARI SAN. VE TIC. A.Ş. | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS
WITHOUT GAS | 🇺🇬Uganda | JERUSALEM PHARMACEUTICA LS CO. LIMITED | active | — |
| Frinase Nasal Spray | 🇹🇿Tanzania | Jerusalem Pharmaceuticals Co. Ltd | active | — |
| FLIXONASE SUSP INS NAS BTE (1 FL X 120 DOS) GLAXOSMITHKLINE suspension pour instillation | 🇲🇬Madagascar | GLAXOSMITHKLINE | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS
WITHOUT GAS | 🇺🇬Uganda | JERUSALEM PHARMACEUTICA LS CO. LIMITED | active | — |
| FLIXONASE SUSP INS NAS BTE (1 FL X 120 DOS) GLAXOSMITHKLINE suspension pour instillation | 🇲🇬Madagascar | GLAXOSMITHKLINE | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS
WITHOUT GAS | 🇺🇬Uganda | SAVA HEALTHCARE LIMITED - | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS WITHOUT
GAS | 🇺🇬Uganda | SAVA HEALTHCARE LIMITED - | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS WITHOUT
GAS | 🇺🇬Uganda | SAVA HEALTHCARE LIMITED - | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS WITHOUT
GAS | 🇺🇬Uganda | JERUSALEM PHARMACEUTICA LS CO. LIMITED | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS
WITHOUT GAS | 🇺🇬Uganda | SAVA HEALTHCARE LIMITED - | active | — |
| FLUTICASONE
PROPIONATE NASAL TOPICAL
SPRAYS WITHOUT
GAS | 🇺🇬Uganda | JERUSALEM PHARMACEUTICA LS CO. LIMITED | active | — |
Showing 50 of 55 registrations. Sign up free to search and export all.
FLUTICASONE PROPIONATE in Africa — Regulatory Overview
FLUTICASONE PROPIONATE is registered across 10 African markets with 55 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Tanzania, Zambia and 6 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 55 registrations, 42 (76%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.